Dryness of the mouth, dizziness, tremor, nervousness, blurred vision and insomnia are the most frequent adverse effects and occur commonly.
In the listing as follows, the following convention is used: MedDRA system organ class or preferred term.
Frequencies are defined as: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); or not known (cannot be estimated from available data). (See table.)
Click on icon to see table/diagram/image
Post-Marketing: Isolated cases of cholestatic hepatitis have been reported.
Reporting of Suspected Adverse Reactions: Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.